Intrathecal treatment of anti-N-Methyl-d-aspartate receptor encephalitis in children

Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

(2014) R. C. Dale et al.   NEUROLOGY

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

(2013) Nuria Gresa-Arribas et al.   LANCET NEUROLOGY

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis

(2012) Lenka Mikasova et al.   BRAIN

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens

(2012) Y. Hacohen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Children's Hospitals across the United States

(2012) Marko Kavcic et al.   JOURNAL OF PEDIATRICS

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis

(2011) E. Martinez-Hernandez et al.   NEUROLOGY

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

(2009) Nicole R. Florance et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation

(2009) RUSSELL C DALE et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children

(2009) Axel Lebas et al.   JOURNAL OF CHILD NEUROLOGY

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

(2008) Josep Dalmau et al.   LANCET NEUROLOGY